Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bengt Winblad

Showing results (511-520 of 538) with videos related to

Pageof 54
Sort By:
Frontiers in Neurology|August 21, 2023
Precision medicine in neurodegeneration: the IHI-PROMINENT projectAshley Tate, Marc Suárez-Calvet, Mats Ekelund, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project surveyLena Sannemann, Theresa Müller, Lisa Waterink, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Alzheimer'S Research & Therapy|July 9, 2016
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery deviceHelga Eyjolfsdottir, Maria Eriksdotter, Bengt Linderoth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2022
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challengeRon L H Handels, Colin Green, Anders Gustavsson, et al.
Journal of Neuroinflammation|December 14, 2023
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's diseaseKaja Nordengen, Bjørn-Eivind Kirsebom, Grit Richter, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International CohortMilica G Kramberger, Bjørn Auestad, Sara Garcia-Ptacek, et al.
Science Advances|January 24, 2024
CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized miceMaría Latorre-Leal, Patricia Rodriguez-Rodriguez, Luca Franchini, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 54

Showing results (511-520 of 538) with videos related to

Sort By:
Pageof 54
Frontiers in Neurology|August 21, 2023
Precision medicine in neurodegeneration: the IHI-PROMINENT projectAshley Tate, Marc Suárez-Calvet, Mats Ekelund, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 5, 2021
General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project surveyLena Sannemann, Theresa Müller, Lisa Waterink, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2021
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological updateMarina Boccardi, Alessandra Dodich, Emiliano Albanese, et al.
Alzheimer'S Research & Therapy|July 9, 2016
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery deviceHelga Eyjolfsdottir, Maria Eriksdotter, Bengt Linderoth, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2022
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challengeRon L H Handels, Colin Green, Anders Gustavsson, et al.
Journal of Neuroinflammation|December 14, 2023
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's diseaseKaja Nordengen, Bjørn-Eivind Kirsebom, Grit Richter, et al.
Journal of Alzheimer'S Disease : JAD|March 18, 2017
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International CohortMilica G Kramberger, Bjørn Auestad, Sara Garcia-Ptacek, et al.
Science Advances|January 24, 2024
CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized miceMaría Latorre-Leal, Patricia Rodriguez-Rodriguez, Luca Franchini, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 54